SARS News and Research

RSS

Severity of current SARS-CoV-2 variants is not linked to the number of mutations

New research from UNC Charlotte's Center for Computational Intelligence to Predict Health and Environmental Risks (CIPHER) has found that the two most prevalent strains of the virus that cause COVID-19, SARS-CoV-2 variants BA.2.86 and JN.1, are not significantly better than their predecessor Omicron at evading immune responses and causing infections despite having a high number of mutations compared to previous variants.

19 Mar 2024

Health workers fear it’s profits before protection as CDC revisits airborne transmission

Four years after hospitals in New York City overflowed with covid-19 patients, emergency physician Sonya Stokes remains shaken by how unprepared and misguided the American health system was.

19 Mar 2024

Genetic key to milder COVID: Certain genes slash severity and death risk in older men

Study found that certain genetic variants in the IL1RN gene significantly reduce COVID-19-related inflammation and mortality in patients, with notable improvements observed in older men carrying specific single-nucleotide variants.

19 Mar 2024

Study reveals why COVID-19 antibodies fade quickly

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the antibody response following SARS-CoV-2 infection.

18 Mar 2024

COVID-19 vaccine associated with reduced risk of cardiac and clot-related complications after SARS-CoV-2 infection

The risk of cardiac and clot-related complications following COVID-19 is substantially reduced in people who receive the COVID-19 vaccination compared with unvaccinated individuals, reports an observational study published online in the journal Heart.

18 Mar 2024

BU study reveals key to combating high-risk neuroblastoma

The MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it difficult to treat various human cancers.

15 Mar 2024

Long COVID manifests as a post-viral syndrome indistinguishable from other respiratory illnesses

Long COVID appears to manifest as a post-viral syndrome indistinguishable from seasonal influenza and other respiratory illnesses, with no evidence of increased moderate-to-severe functional limitations a year after infection, according to new research being presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April).

14 Mar 2024

New drug candidate designed at the atomic level could help halt emerging SARS-CoV-2 variants

Although COVID-19 has faded from the headlines, SARS-CoV-2 – the coronavirus behind the pandemic – is still rampantly infecting people around the world.

14 Mar 2024

Anti-inflammatory gene variant shields men under 75 from severe COVID-19

A certain variant of a key anti-inflammatory gene protects men under age 75 from severe illness and death when hospitalized from COVID-19, a genetic analysis of their blood shows.

14 Mar 2024

Major study reveals COVID vaccines protect against serious cardiac events post-infection

The impact of SARS-CoV-2 vaccination on thromboembolic and cardiovascular complication risk.

13 Mar 2024

Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccines

Researchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCLH have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve.

11 Mar 2024

COVID-19 transmission from mothers to newborns is low, study reveals

A study by KK Women's and Children's Hospital (KKH), Singapore General Hospital (SGH) and National University Hospital (NUH) has revealed that COVID-19 transmission from mothers to their newborns is low.

11 Mar 2024

Lancet study exposes COVID-19's far-reaching consequences on mortality and life expectancy

A new study published in The Lancet reveals never-before-seen details about staggeringly high mortality from the COVID-19 pandemic within and across countries.

11 Mar 2024

AI framework can identify and track new and concerning COVID-19 variants

Scientists at The Universities of Manchester and Oxford have developed an AI framework that can identify and track new and concerning COVID-19 variants and could help with other infections in the future.

11 Mar 2024

mRNA vaccines train T cells in waves, study shows

mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in combating coronavirus 19 (COVID-19).

9 Mar 2024

Researchers forge new path to combat viruses and cancers with helicase inhibitors

Helicases are enzymes that unwind DNA and RNA. They're central to cellular life, implicated in a number of cancers and infections-;and, alas, extraordinarily difficult to target with drugs.

9 Mar 2024

Man takes 217 COVID vaccines with no ill effects, shows immune boost

A case report of a 62-year-old man receiving 217 SARS-CoV-2 vaccinations over 29 months reveals no adverse effects, increased T-cells, and spike-specific antibodies, providing unique insights into the effects of hyper-vaccination on immune responses.

7 Mar 2024

Understanding long COVID: A call for better diagnosis and treatment

A recent review in Nature Reviews Microbiology summarizes the complex mechanisms, significant impacts, and the urgent need for enhanced diagnostics and treatments for long COVID, affecting over 65 million people globally with diverse, debilitating symptoms and systemic health issues.

7 Mar 2024

Proteins regulating plasminogen-plasmin levels can help predict COVID-19 severity

The global impact of the COVID-19 pandemic on healthcare systems has been significant. The sudden surge in infected cases overwhelmed hospitals and disrupted routine healthcare services, thus further worsening public health.

7 Mar 2024

"Copy-paste" genetic mechanism increases the genetic diversity of malaria parasite

By dissecting the genetic diversity of the most deadly human malaria parasite – Plasmodium falciparum – researchers at EMBL's European Bioinformatics Institute (EMBL-EBI) have identified a mechanism of 'copy-paste' genetics that increases the genetic diversity of the parasite at accelerated time scales.

7 Mar 2024

SARS News and Research

Severity of current SARS-CoV-2 variants is not linked to the number of mutations

Health workers fear it’s profits before protection as CDC revisits airborne transmission

Genetic key to milder COVID: Certain genes slash severity and death risk in older men

Study reveals why COVID-19 antibodies fade quickly

COVID-19 vaccine associated with reduced risk of cardiac and clot-related complications after SARS-CoV-2 infection

BU study reveals key to combating high-risk neuroblastoma

Long COVID manifests as a post-viral syndrome indistinguishable from other respiratory illnesses

New drug candidate designed at the atomic level could help halt emerging SARS-CoV-2 variants

Anti-inflammatory gene variant shields men under 75 from severe COVID-19

Major study reveals COVID vaccines protect against serious cardiac events post-infection

Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccines

COVID-19 transmission from mothers to newborns is low, study reveals

Lancet study exposes COVID-19's far-reaching consequences on mortality and life expectancy

AI framework can identify and track new and concerning COVID-19 variants

mRNA vaccines train T cells in waves, study shows

Researchers forge new path to combat viruses and cancers with helicase inhibitors

Man takes 217 COVID vaccines with no ill effects, shows immune boost

Understanding long COVID: A call for better diagnosis and treatment

Proteins regulating plasminogen-plasmin levels can help predict COVID-19 severity

"Copy-paste" genetic mechanism increases the genetic diversity of malaria parasite

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News